Congenital Heart DiseaseLbHNCT06267430
Learning by Heart: The Effectiveness of an EF Training Program for Pre-schoolers With Critical CHD
A study testing Kleuter Extra training program in people with Congenital Heart Disease and Executive Dysfunction, run by Erasmus Medical Center at 3 sites in Netherlands.
Trial summary
Advances in prenatal and neonatal care have improved outcomes in children with critical congenital heart disease (CCHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. Read more about this study
- Who is it for?
- Ages 4 to 7 years
- Conditions the study is for
- Congenital Heart Disease, Executive Dysfunction, Attention Disorder
- What is being tested?
- Kleuter Extra training program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 103 participants
- Where
- 3 sitesNetherlands
- Study dates
- 1 May 2024to 31 Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 4 to 7 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
None listed.
Who cannot join
- Children with severe brain damage (estimated IQ < 55)
- Genetic syndromes known to directly affect cognitive performance (e.g. Down syndrome)
- Children with severe psychiatric disorders upon inclusion that require treatment first, such as a posttraumatic stress disorder, separation anxiety disorder, or reactive attachment disorder.
Trial locations and contacts
3 sites in 1 country.
Netherlands3 sites
University Medical Center - Beatrix children's hospital Groningen
Groningen, Provincie Groningen, 9713GZ
Erasmus Medical Center Sophia Children's Hospital
Rotterdam, Rotterdam, 3015CN
University Medical Center - Wilhelmina children's hospital Utrecht
Utrecht, Utrecht, 3584EA
About this study
Official title: The Effectiveness of a Personalized Executive Functioning Training Program for Pre-schoolers With a Critical Congenital Heart Disease
Advances in prenatal and neonatal care have improved outcomes in children with critical congenital heart disease (CCHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. EF problems have cascading negative effects on a child's development. New insights in EF development suggest that in otherwise physically healthy young children, EF can be improved by training. In a pilot study funded by Stichting Hartekind, the investigators studied the feasibility of a personalized EF training program called 'Kleuter Extra' and the results were promising. Therefore, the current study will investigate the effectiveness of this program in 4-6-year-old children with CCHD. The researchers will also explore interactions between the parent-child relationship and EF development of the child as psychosocial difficulties in these children and their parent(s) and/or caretaker(s) may impact EF-development. If found effective, EF training for children with CCHD will improve their developmental outcome.
Read the detailed description
Advances in prenatal and neonatal care have improved outcome in children with critical congenital heart disease (CCHD), with survival rates up to 90%. With the increase in survival, neurocognitive problems and psychological maladjustment have become more apparent in these children, such as impairments in their executive functioning. Executive functioning (EF) is an umbrella-term for several higher-order cognitive processes crucial for self-regulated and goal directed behavior. Frequently postulated components of EF are inhibition, including motor inhibition, and attention, working memory, and cognitive flexibility. Early EF problems often result in emotion regulation difficulties, behavioural problems, social problems, and learning problems, which can lead to diminished functioning in social domains and lower achievement levels in education and employment status. Children with CHD might be rendered even more vulnerable for EF-problems since EF development is embedded within the social context of a child. There is an increasing understanding of how naturally distressing the CHD diagnosis and treatment can be for parents, which can impair the interactions with their child and in turn might negatively impact the child's EF development. Looking at the reciprocal nature of relationships, the child's illness and/or emotional and behavioural problems that may be associated with EF difficulties might negatively impact the parent-child relationship, parenting behaviour and parental wellbeing. However, these relations are poorly understood, especially regarding fathers. A greater understanding of the interplay between biological and psychosocial factors on EF-development is needed to promote optimal developmental outcomes for these vulnerable children.
New insights suggest that EF can be improved by training. Due to neural plasticity, the window for effective training seems to be between the ages of two and six years. After this time frame, improvements in EF may not retain after training or not generalize to off-task functions. Current EF training programs are not personalised ('adaptive') but offer the same program regardless of the specific child's EF dysfunctions, which may explain their limited effects. There is presently no effective EF training program for children with CHD.
In a pilot study funded by Stichting Hartekind, the researchers investigated the feasibility of a personalised EF training program called 'KleuterExtra' in 4-6 year old children with critical CHD. Within a week, 31 children were (self-) referred for the study, indicating a great clinical need. Directly after training, children showed clinically relevant improvement on the specific EFs targeted in training, with Cohen's d effect sizes ranging from 0.19 to 2.41 (>1.00 on 5 out of 9 tasks). Improvement was also found in untrained EFs and tasks that combined multiple EFs, indicating a generalization effect. Parents and teachers spontaneously reported positive results in daily life. Based on these promising results, the investigators designed the current randomized, controlled study to test the effectiveness of this training program in pre-schoolers with severe CHD.
Given the above, the investigators designed this study to investigate the effectiveness of a tailored EF training program for preschoolers with CCHD. Secondary aim was to explore interactions between the parent-child relationship and the EF development of the child. If found effective, EF training for children with CCHD will improve their developmental outcome.
- Being tested
- Kleuter Extra training program
- Keywords
- Congenital heart disease, Preschooler, Executive functions, Training
- Medical subject headings
- Heart Defects, Congenital, Cognition Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Kleuter Extra training programBehavioural
The intervention was described in the included arm/group explanation.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | The participants allocated to the intervention group will receive the personalised training program 'KleuterExtra', developed by dr. Lex Wijnroks from Utrecht University. All parents will receive the book 'Speels Brein' ('Playful Brain') and an age-appropriate addition for preschoolers to this book. Receives: Behavioral: Kleuter Extra training program |
| Control group | No intervention | As described, the parents of the control group will also receive the book 'Speels Brein' ('Playful Brain') and the age-appropriate addition for preschoolers to this book. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Kleuter Extra test battery
The primary endpoint is a single composite score on the 'KleuterExtra' EF test battery, calculated as the mean z-score (mean = 0, SD = 1) of the ten tasks of the test battery. The composite score has no fixed minimum or maximum, and a higher score indicates a better outcome.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Secondary outcomes (11)
EF functioning
Scores on the 10 individual tasks of the 'KleuterExtra' test battery, four EF domain scores (inhibition, attention, working memory, cognitive flexibility), and an integrated EF score (based on task 'Head-Toes-Knees-Shoulders'; HTKS).
Raw task scores:
- 'Pencil Tap': 0 to 100
- 'Go/No go animals': 0 to 20
- 'Statue task': 0 to 30
- 'Search task': 0 to 18
- 'Sustained attention': 0 to 30
- 'Corsi blocks': 0 to 15
- 'Dots': 0 to 74
- 'Digit Recall': 0 to 54
- 'Three is Correct': 0 to 68
- 'HTKS': 0 to 52
A higher score indicates a better outcome for all tasks, except 'Go/No go animals' (reverse scored). Raw scores are converted to z-scores (mean = 0, SD =1) for analysis. A higher z-score indicates a better outcome. Domain scores are calculated as the mean z-score of the tasks within each domain.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Information processing
Cognitive Proficiency Index of the WPPSI-IV-NL: index score (mean = 100, SD =15, range 40-160), and a higher score indicates a better outcome. The CPI is based on four subtests (scaled scores 1-19):
- subtest 'Picture Memory'
- subtest 'Zoo Locations'
- subtest 'Bug Search'
- subtest 'Cancellation'
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Executive functioning in daily life - completed by the parent(s)
Behavior Rating Inventory of Executive Function - Preschool Version questionnaire (BRIEF-P): t-scores range from 20-80, higher scores indicate worse outcome. The three calculated main indexes (inhibitory self-control, flexibility, and metacognition) will be used for the current trial.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Behavioral and emotional difficulties of the child - completed by the parent(s)
Child Behavioral Checklist questionnaire 1,5 - 5 years old (CBCL): t-scores range from 50-100, higher scores indicate worse outcome. The three overall domains (internalizing behavior, externalizing behavior, and the total sum of problems) will be used for the current trial.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Quality of the child's life - completed by the parent(s)
Preschool Children Quality of Life questionnaire (TAPQOL): scale scores range from 0 - 100, higher score indicates better outcome. All twelve scales will be used for the current trial: stomach problems, skin problems, lung problems, sleeping problems, appetite, problem behavior, positive mood, anxiety, liveliness, social functioning, motor functioning, and communication.
Measured: 9 weeks after baseline, additional measures at 6 months and 12 months after baseline.
Emotional distress parent - completed by the parent(s)
Depression, Anxiety, Stress Scale (DASS-21): subscale scores (depression, anxiety, stress) range from 0-21 and the total score ranges from 0-63. A higher score indicates worse outcome. These four scales will be used for this trial.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Parental trauma
PCL-5 questionnaire ('PCL-5' is the title, scores range from 0-80, higher score indicates worse outcome)
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Parenting behavior questionnaire - completed by the parent(s)
Parenting Behavior questionnaire (PABI; Dutch title 'Vragenlijst over opvoedgedrag'): T-scores range from 20-80. The three adaptive domains (warmth, structure, and autonomy), and three maladaptive domains (hostility, coercion, and excessive protection) will be used for the current trial. Higher scores indicate a better outcome on the adaptive domains, and a worse outcome on the maladaptive domains.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Child demographics: schooling - completed by the parents
Additional support in school, type, being held back a year (qualitative data, designed by the study group)
Measured: Baseline. Changes are recorded at 9 weeks, 6 months, and 12 months after baseline.
Behavioral and emotional difficulties teacher's perspective
Teacher's Report Form questionnaire (C-TRF): t-scores range from 50-100, higher scores indicate worse outcome. The three overall domains (internalizing behavior, externalizing behavior, and the total sum of problems) will be used for the current trial.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Executive functioning child in daily life teacher's perspective
Behavior Rating Inventory of Executive Function questionnaire - teachers (BRIEF-P); t-scores range from 20-80, higher scores indicate worse outcome.
Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Feb 2024
- Study start1 May 2024
- Primary completion29 Oct 2025
- Study completion31 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Congenital Heart DiseaseStudies of the same condition, open and under way.
- More trials run by Erasmus Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 103 participants (actual)
Sponsor and investigators
- Lead sponsor
- Erasmus Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Andre Rietman, Erasmus Medical Center
- Investigators
- André Rietman, Principal investigator, Erasmus Medical CenterRenske Schappin, Principal investigator, Erasmus Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06267430
- Sponsor's protocol ID
- NL85141.078.23
- Acronym
- LbH
- Status last verified
- Oct 2026
- First submitted
- 12 Dec 2023
- Last updated
- 9 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effectiveness of a Personalized Executive Functioning Training Program for Pre-schoolers With a Critical Congenital Heart Disease
- ClinicalTrials.gov ID
- NCT06267430
- Acronym / sponsor ID
- LbH / NL85141.078.23
- Keywords
- Congenital heart disease, Preschooler, Executive functions, Training
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 103 participants (actual)
- Lead sponsor
- Erasmus Medical CenterUniversity, hospital or other
- Study start
- 1 May 2024 (actual)
- Primary completion
- 29 Oct 2025 (actual)
- Study completion
- 31 Oct 2026 (estimated)
- First posted
- 20 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Advances in prenatal and neonatal care have improved outcomes in children with critical congenital heart disease (CCHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. EF problems have cascading negative effects on a child's development. New insights in EF development suggest that in otherwise physically healthy young children, EF can be improved by training. In a pilot study funded by Stichting Hartekind, the investigators studied the feasibility of a personalized EF training program called 'Kleuter Extra' and the results were promising. Therefore, the current study will investigate the effectiveness of this program in 4-6-year-old children with CCHD. The researchers will also explore interactions between the parent-child relationship and EF development of the child as psychosocial difficulties in these children and their parent(s) and/or caretaker(s) may impact EF-development. If found effective, EF training for children with CCHD will improve their developmental outcome.
Detailed description
Advances in prenatal and neonatal care have improved outcome in children with critical congenital heart disease (CCHD), with survival rates up to 90%. With the increase in survival, neurocognitive problems and psychological maladjustment have become more apparent in these children, such as impairments in their executive functioning. Executive functioning (EF) is an umbrella-term for several higher-order cognitive processes crucial for self-regulated and goal directed behavior. Frequently postulated components of EF are inhibition, including motor inhibition, and attention, working memory, and cognitive flexibility. Early EF problems often result in emotion regulation difficulties, behavioural problems, social problems, and learning problems, which can lead to diminished functioning in social domains and lower achievement levels in education and employment status. Children with CHD might be rendered even more vulnerable for EF-problems since EF development is embedded within the social context of a child. There is an increasing understanding of how naturally distressing the CHD diagnosis and treatment can be for parents, which can impair the interactions with their child and in turn might negatively impact the child's EF development. Looking at the reciprocal nature of relationships, the child's illness and/or emotional and behavioural problems that may be associated with EF difficulties might negatively impact the parent-child relationship, parenting behaviour and parental wellbeing. However, these relations are poorly understood, especially regarding fathers. A greater understanding of the interplay between biological and psychosocial factors on EF-development is needed to promote optimal developmental outcomes for these vulnerable children.
New insights suggest that EF can be improved by training. Due to neural plasticity, the window for effective training seems to be between the ages of two and six years. After this time frame, improvements in EF may not retain after training or not generalize to off-task functions. Current EF training programs are not personalised ('adaptive') but offer the same program regardless of the specific child's EF dysfunctions, which may explain their limited effects. There is presently no effective EF training program for children with CHD.
In a pilot study funded by Stichting Hartekind, the researchers investigated the feasibility of a personalised EF training program called 'KleuterExtra' in 4-6 year old children with critical CHD. Within a week, 31 children were (self-) referred for the study, indicating a great clinical need. Directly after training, children showed clinically relevant improvement on the specific EFs targeted in training, with Cohen's d effect sizes ranging from 0.19 to 2.41 (>1.00 on 5 out of 9 tasks). Improvement was also found in untrained EFs and tasks that combined multiple EFs, indicating a generalization effect. Parents and teachers spontaneously reported positive results in daily life. Based on these promising results, the investigators designed the current randomized, controlled study to test the effectiveness of this training program in pre-schoolers with severe CHD.
Given the above, the investigators designed this study to investigate the effectiveness of a tailored EF training program for preschoolers with CCHD. Secondary aim was to explore interactions between the parent-child relationship and the EF development of the child. If found effective, EF training for children with CCHD will improve their developmental outcome.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: Kleuter Extra training programThe participants allocated to the intervention group will receive the personalised training program 'KleuterExtra', developed by dr. Lex Wijnroks from Utrecht University. All parents will receive the book 'Speels Brein' ('Playful Brain') and an age-appropriate addition for preschoolers to this book. |
| Control group | No intervention | –As described, the parents of the control group will also receive the book 'Speels Brein' ('Playful Brain') and the age-appropriate addition for preschoolers to this book. |
Who may qualify
- Ages
- 4 to 7 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (0 listed)
Key exclusion criteria (3 listed)
- Children with severe brain damage (estimated IQ < 55)
- Genetic syndromes known to directly affect cognitive performance (e.g. Down syndrome)
- Children with severe psychiatric disorders upon inclusion that require treatment first, such as a posttraumatic stress disorder, separation anxiety disorder, or reactive attachment disorder.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Kleuter Extra training programThe intervention was described in the included arm/group explanation. | Behavioural | Intervention group |
Primary outcome
Kleuter Extra test battery
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
The primary endpoint is a single composite score on the 'KleuterExtra' EF test battery, calculated as the mean z-score (mean = 0, SD = 1) of the ten tasks of the test battery. The composite score has no fixed minimum or maximum, and a higher score indicates a better outcome.
11 secondary outcomes
EF functioning
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Information processing
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Executive functioning in daily life - completed by the parent(s)
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Behavioral and emotional difficulties of the child - completed by the parent(s)
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Quality of the child's life - completed by the parent(s)
Time frame: 9 weeks after baseline, additional measures at 6 months and 12 months after baseline.
Emotional distress parent - completed by the parent(s)
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Parental trauma
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Parenting behavior questionnaire - completed by the parent(s)
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Child demographics: schooling - completed by the parents
Time frame: Baseline. Changes are recorded at 9 weeks, 6 months, and 12 months after baseline.
Behavioral and emotional difficulties teacher's perspective
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Executive functioning child in daily life teacher's perspective
Time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Congenital Heart Disease
Not yet recruitingPhase 1/2
EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)
Heterozygous Familial Hypercholesterolemia (HeFH)
RecruitingObservational study
Natural History of Noncirrhotic Portal Hypertension
Cystic Fibrosis, Immunologic Deficiency Syndrome
RecruitingObservational study
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Metabolic Disease, Obesity
Enrolling by invitationObservational study
Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
Sickle Cell Disease
Recruiting
Ventilator Pressure and Optimization of Compliance and Hemodynamics
Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
André Rietman principal investigator
Erasmus Medical Center
Renske Schappin principal investigator
Erasmus Medical Center
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kleuter Extra training program in people with Congenital Heart Disease and Executive Dysfunction, run by Erasmus Medical Center at 3 sites in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Kleuter Extra test battery (time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.